Myles Edward H

COO & CFO Myles Edward H sells 142,292 shares for $5.1M; reduces holding by 56.1% to 111,345 shares

Myles Edward H executed 2 separate sales totaling 142,292 shares for $5,068,974.19 at an average price of $35.62 per share, reducing his stake from 253,637 to 111,345 shares—a 56.1% reduction in holdings. The current stock price of $35.79 is 23.4% below the 52-week high of $46.73 and down 6.2% over the past 30 days and 14.1% over 90 days. At Scholar Rock, his prior 5 trades show a pattern of poor timing at the 90-day measurement mark: 0 of 4 measurable prior sells were well-timed (stock rose after the sale in all cases), with 90-day returns ranging from +22.8% to +76.4%. The company posted a 76.4% annual revenue increase to $33.2M but remains unprofitable with a $-64.5M net loss in the most recent full fiscal year. The substantial reduction in the CFO's personal stake during a period of declining share price and in the context of the company's ongoing losses warrants attention to whether this magnitude of insider liquidation reflects broader capital allocation or operational concerns.

COO & CFO Myles Edward H sold 12,539 shares of SRRK at $44.20; still holds 148,549 shares post-transaction.

Myles Edward H sold 12,539 shares (7.8% of his pre-transaction holdings) at $44.20 on 2025-01-16, with the stock near its 52-week high of $45.73. While his cross-ticker track record shows 5 prior sells with an average 90-day return of +57.7%, at SRRK specifically, his prior 5 trades show a 0.00% well-timed rate at the 90-day mark—none of those sales preceded subsequent declines. The company posted $33.2M quarterly revenue with strong +76.4% annual growth, but remains unprofitable with $-64.5M net income over its most recent full fiscal year. This sale occurs as the stock has rallied +60.6% over 90 days, and the insider's historical timing at this ticker has not signaled a pattern of selling before downturns.

COO & CFO Myles Edward H sells 37,187 shares of SRRK at $34.90; stock now $26.14, down 23.8% from 52-week high amid -23.8% decline from sale price.

Myles Edward H, the COO & CFO, sold 37,187 shares (18.8% of his pre-transaction holdings) on 2024-10-08 at $34.90, one day after executing four additional sales at SRRK on 2024-10-07. The current price of $26.14 is now 25.1% below the sale price, suggesting the sale occurred near a local peak as the stock has declined substantially since the transaction. Scholar Rock is unprofitable (net income of $-58.5M on latest quarterly revenue of $33.2M) despite strong annual revenue growth of +76.4%, creating a high-growth/unprofitable profile typical of biotech firms where execution risk is elevated. The concentrated selling activity within 24 hours (five total transactions across two consecutive days) by the CFO warrants examination of whether capital allocation or liquidity needs drove the activity, particularly given the company's cash-burn profile and the CFO's reduction of holdings by approximately one-fifth of his pre-transaction position.

COO & CFO Myles Edward H sold 206,240 shares for $5,477,545.64 across 4 transactions on 2024-10-07 at $25.61–$29.05.

Myles Edward H, serving as COO and CFO, executed 4 separate sales totaling 206,240 shares for $5,477,545.64, reducing his holdings by 56.1% from 367,328 to 161,088 shares. The stock has appreciated dramatically from the sale prices ($25.61–$29.05 blended average $26.56) to the current price of $34.28, placing the stock at its 52-week high and up +326.9% over the past 30 days and +335.0% over 90 days. The company remains unprofitable with a net loss of $58,508,000 in its most recent quarter despite strong annual revenue growth of +76.4%, indicating the stock's recent surge reflects momentum or market sentiment rather than near-term earnings improvement. A substantial reduction in CFO equity ownership during explosive price appreciation warrants investor attention to whether the transaction reflects near-term liquidity needs versus forward-looking strategic considerations.